Verition Fund Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,900
Closed -$1.33M 2859
2023
Q4
$1.33M Buy
2,900
+1,600
+123% +$789K 0.01% 1038
2023
Q3
$632K Buy
+1,300
New +$611K 0.01% 1299
2023
Q1
Sell
-4,300
Closed -$2.2M 2338
2022
Q4
$2.2M Sell
4,300
-400
-9% -$210K 0.03% 588
2022
Q3
$2.28M Buy
+4,700
New +$2.29M 0.03% 822
2022
Q2
Sell
-5,700
Closed -$2.48M 2671
2022
Q1
$2.48M Buy
5,700
+800
+16% +$335K 0.03% 814
2021
Q4
$2.27M Buy
+4,900
New +$2.17M 0.02% 804

Other funds holding HUM

Verition Fund Management's HUM Position: Q2 2026 in Review

Verition Fund Management sold out of Humana (HUM) in Q2 2026, closing a stake of 1,407 shares — an estimated $244K sold.

Verition Fund Management first reported a position in HUM in Q3 2013 and held it in 37 quarters. The position peaked at $16.6M in Q4 2023. 928 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Verition Fund Management reported no remaining Humana position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 1,407 Humana shares in Q2 2026, an estimated $244K.
  • Verition Fund Management first reported a position in Humana in Q3 2013 and held it in 37 quarters.
  • Verition Fund Management's Humana position peaked at $16.6M in Q4 2023.
  • 928 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.